EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 110 filers reported holding EPIZYME INC in Q1 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $50,000 | -59.3% | 20,000 | -16.8% | 0.00% | -66.7% |
Q3 2021 | $123,000 | -43.3% | 24,037 | -8.1% | 0.00% | -40.0% |
Q2 2021 | $217,000 | -1.4% | 26,161 | +3.7% | 0.01% | 0.0% |
Q1 2021 | $220,000 | -20.6% | 25,227 | -1.2% | 0.01% | 0.0% |
Q4 2020 | $277,000 | -15.0% | 25,534 | -6.5% | 0.01% | -44.4% |
Q3 2020 | $326,000 | -10.7% | 27,304 | +20.1% | 0.01% | -10.0% |
Q2 2020 | $365,000 | -6.2% | 22,725 | -9.4% | 0.01% | -33.3% |
Q1 2020 | $389,000 | -47.3% | 25,077 | -16.4% | 0.02% | +25.0% |
Q4 2019 | $738,000 | +10.1% | 30,000 | -53.8% | 0.01% | -14.3% |
Q3 2019 | $670,000 | -17.9% | 65,000 | 0.0% | 0.01% | -36.4% |
Q2 2019 | $816,000 | -12.2% | 65,000 | -13.3% | 0.02% | -4.3% |
Q1 2019 | $929,000 | +77.3% | 75,000 | -11.8% | 0.02% | +4.5% |
Q4 2018 | $524,000 | +23.6% | 85,000 | +112.5% | 0.02% | +100.0% |
Q3 2018 | $424,000 | +14.6% | 40,000 | +46.3% | 0.01% | +22.2% |
Q2 2018 | $370,000 | +39.1% | 27,341 | +82.3% | 0.01% | +12.5% |
Q1 2018 | $266,000 | – | 15,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |